PURE Bioscience Raises $1.27 Million from Warrant Exercise
2:17 PM May 24, 2016May 24, 2016 OTC Disclosure & News Service, PURE – PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company raised $1.27 million from the recent exercise by all of the holders of the 2,820,670 warrants expiring May 23, 2016. Use of proceeds will include the commercialization of FDA approved PURE Control® antimicrobial as a processing aid for fresh produce and for raw poultry. PURE Control is a superior, broad spectrum,
Read more